A study by Sun et al. [35] on 82 patients with lung cancer found that serum levels of NSE decreased significantly after radiotherapy, suggesting that these blomarkers can be used to evaluate the effectiveness of treatment. This evidence concerns the gene ENO2 and lung cancer.